These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 35743189)

  • 41. The domiciliary management of genital tract infection.
    Ridgway GL
    J Antimicrob Chemother; 1993 Jul; 32 Suppl A():11-6. PubMed ID: 8407693
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Combination with antimicrobial peptide lyses improves loop-mediated isothermal amplification based method for Chlamydia trachomatis detection directly in urine sample.
    Jevtuševskaja J; Uusna J; Andresen L; Krõlov K; Laanpere M; Grellier T; Tulp I; Langel Ü
    BMC Infect Dis; 2016 Jul; 16():329. PubMed ID: 27412444
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genital infections with Chlamydia trachomatis and Neisseria gonorrhoeae in Ghanaian women.
    Bentsi C; Klufio CA; Perine PL; Bell TA; Cles LD; Koester CM; Wang SP
    Genitourin Med; 1985 Feb; 61(1):48-50. PubMed ID: 3936773
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Drug treatment of genital chlamydial infection.
    Drug Ther Bull; 2001 Apr; 39(4):27-30. PubMed ID: 11329797
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of treatment for Chlamydia trachomatis during pregnancy.
    Rastogi S; Das B; Salhan S; Mittal A
    Int J Gynaecol Obstet; 2003 Feb; 80(2):129-37. PubMed ID: 12566185
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Population-Based Study of Prediagnostic Antibodies to Chlamydia trachomatis in Relation to Adverse Pregnancy Outcome.
    Rantsi T; Joki-Korpela P; Wikström E; Öhman H; Bloigu A; Lehtinen M; Gissler M; Tiitinen A; Paavonen J; Surcel HM
    Sex Transm Dis; 2016 Jun; 43(6):382-7. PubMed ID: 27196260
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prediction of efficacy of antimicrobial agents in treatment of infections due to Chlamydia trachomatis.
    Bowie WR; Lee CK; Alexander ER
    J Infect Dis; 1978 Nov; 138(5):655-9. PubMed ID: 712119
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chlamydia trachomatis: impact on human reproduction.
    Paavonen J; Eggert-Kruse W
    Hum Reprod Update; 1999; 5(5):433-47. PubMed ID: 10582782
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Chlamydia trachomatis pneumonia].
    Motai Y; Torikai K
    Ryoikibetsu Shokogun Shirizu; 1999; (24 Pt 2):230-2. PubMed ID: 10201183
    [No Abstract]   [Full Text] [Related]  

  • 50. Comparative in vitro activity of garenoxacin against Chlamydia spp.
    Donati M; Pollini GM; Sparacino M; Fortugno MT; Laghi E; Cevenini R
    J Antimicrob Chemother; 2002 Sep; 50(3):407-10. PubMed ID: 12205067
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Advances in the treatment of Chlamydia trachomatis infection].
    Shi LL; Lu JC; Huangfu YM
    Zhonghua Nan Ke Xue; 2005 Apr; 11(4):296-8. PubMed ID: 15921264
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of a strong and specific antichlamydial N-acylhydrazone.
    Zhang H; Kunadia A; Lin Y; Fondell JD; Seidel D; Fan H
    PLoS One; 2017; 12(10):e0185783. PubMed ID: 28973037
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Improved plaque assay identifies a novel anti-Chlamydia ceramide derivative with altered intracellular localization.
    Banhart S; Saied EM; Martini A; Koch S; Aeberhard L; Madela K; Arenz C; Heuer D
    Antimicrob Agents Chemother; 2014 Sep; 58(9):5537-46. PubMed ID: 25001308
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A phase-II study of trovafloxacin for the treatment of Chlamydia trachomatis infections.
    Martin DH; Jones RB; Johnson RB
    Sex Transm Dis; 1999 Aug; 26(7):369-73. PubMed ID: 10458628
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antichlamydial activities of newly developed fluoroquinolones and their potential future role in the treatment of chlamydial respiratory infections.
    Soejima R; Niki Y; Kishomoto T; Kimura M; Kubota Y
    Drugs; 1995; 49 Suppl 2():257-9. PubMed ID: 8549323
    [No Abstract]   [Full Text] [Related]  

  • 56. Effects of quinolone analog CI-960 in a monkey model of Chlamydia trachomatis salpingitis.
    Patton DL; Cosgrove YT; Kuo CC; Campbell LA
    Antimicrob Agents Chemother; 1993 Jan; 37(1):8-13. PubMed ID: 8381642
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chlamydial and gonococcal cervicitis in HIV-seropositive and HIV-seronegative pregnant women in Bangkok: prevalence, risk factors, and relation to perinatal HIV transmission.
    Chaisilwattana P; Chuachoowong R; Siriwasin W; Bhadrakom C; Mangclaviraj Y; Young NL; Chearskul S; Chotpitayasunondh T; Mastro TD; Shaffer N
    Sex Transm Dis; 1997 Oct; 24(9):495-502. PubMed ID: 9339966
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Epidemiologic characteristics of sexually transmitted infection/coinfection with Chlamydia trachomatis and Neisseria gonorrhoeae.
    Cerkez-Habek J; Habek D
    Acta Med Croatica; 2001; 55(4-5):191-201. PubMed ID: 12398023
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Activities of first-choice antimicrobials against gamma interferon-treated Chlamydia trachomatis differ in hypoxia.
    Shima K; Klinger M; Solbach W; Rupp J
    Antimicrob Agents Chemother; 2013 Jun; 57(6):2828-30. PubMed ID: 23478971
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effect of antibiotic treatment on active trachoma and ocular Chlamydia trachomatis infection.
    Mabey D; Solomon A
    Expert Rev Anti Infect Ther; 2003 Aug; 1(2):209-16. PubMed ID: 15482115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.